2021 – Reliable identification of cardiac conduction abnormalities in drug discovery using automated patch clamp II: Best practices for NaV1.5 peak current in a high throughput screening environment

For reliable identification of cardiac safety risk, compounds should be screened for activity on cardiac ion channels in addition to hERG, including NaV1.5 and CaV1.2. We identified different parameters that might affect IC₅₀s of compounds on NaV1.5 peak and late currents recorded using automated patch clamp (APC) and suggest outlines for best practices.